4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Assembly Biosciences, Inc. (ASMB) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 73 employees. Its market capitalization is roughly $506 million. In the fiscal year ended 2025-12-31, ASMB reported $72M in revenue and ($6M) in net income.
Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
Interactive charts & full statements → Open the ASMB valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $72M | $28M | $7M | $0M | — |
| Operating Income (EBIT) | ($12M) | ($45M) | ($65M) | ($94M) | — |
| Net Income | ($6M) | ($40M) | ($61M) | ($93M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $8M | $42M | $11M | $10M | $9M | — |
| Operating Income (EBIT) | ($11M) | $20M | ($11M) | ($11M) | ($10M) | — |
| Net Income | ($9M) | $22M | ($9M) | ($10M) | ($9M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $258M | $119M | $137M | $102M | — |
| Total Liabilities | $51M | $86M | $96M | $19M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ASMB viewer.
About TickerBase · Data methodology & sources